Alnylam Posts Q4 Loss as R&D Spending Offsets Revenue Jump, Offers New Details on Alliances

During the firm's fourth-quarter conference call, Alnylam President and COO Barry Greene provided some new details about the company's alliances with Novartis and Roche.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.